• Users Online: 138
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 3  |  Issue : 1  |  Page : 30-33

Mean platelet volume as a new biomarker for left atrial thrombus or thromboembolic events in nonvalvular atrial fibrillation: Weighing the evidence


1 Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia
2 Interventional Cardiologist, Department of Cardiology, Kanujoso Djatiwibowo Hospital, Balikpapan, Indonesia
3 Internist, Department of Internal Medicine, Berkah Pandeglang Hospital, Banten, Indonesia

Correspondence Address:
Dr. Bayushi Eka Putra
Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta
Indonesia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/IJHR.IJHR_18_16

Rights and Permissions

Background: Mean platelet volume (MPV) is a new biomarker for left atrial appendage (LAA) thrombus or thromboembolic event with great potential. Considering its applicability and cost, it can be the chosen examination for the detection of LAA thrombus in patients with nonvalvular atrial fibrillation. This study aimed to evaluate MPV as a new biomarker for left atrial thrombus or thromboembolic events in comparison with transesophageal echocardiography. Methods: We did electronic searches on PubMed, ScienceDirect, and SpringerLink databases. Appraisal of studies was performed using critical appraisal sheets provided by the Centre for Evidence-Based Medicine. Test characteristic was extracted from the literature. Meanwhile, sensitivity, specificity, positive predictive value, and negative predictive value (NPV) were calculated based on the test characteristic. Results: Two studies met the selection criteria. Different cutoff was used in the studies (>10.5 fL and >9.4 fL) which showed significant differences in sensitivity, specificity, and positive predictive value. However, both the studies have fairly high NPV (78.95% and 72.65%, respectively). Conclusion: Currently, the best MPV cutoff value in determining the absence of thrombus in the left atrium is 10.5 fL. Although the clinical application of MPV remains limited, it can be further improved by more studies to obtain the optimal cutoff value and to increase the value of MPV by combining with other biomarkers and clinical prediction tools.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed282    
    Printed38    
    Emailed0    
    PDF Downloaded57    
    Comments [Add]    

Recommend this journal